Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
NCT03182738
AIDS (Acquired Immunodeficiency Syndrome), Acquired Immunodeficiency Syndrome
New York, United States
View Trial DetailsNCT Number: NCT01992887
Retention of patients in HIV care following diagnosis and enrollment is critical to the long-term success of HIV care and treatment scale-up. The goal of this study is to better understand the factors that influence retention and engagement in HIV care among adult patients who are enrolled in HIV care and are not yet eligible for antiretroviral therapy (ART). The study will be conducted at four HIV care and treatment clinics (CTCs) in Kagera Region, Tanzania. This is a mixed-methods study with both qualitative (interviews) and quantitative (surveys) data collection. Our findings will be important towards designing programs that help patients remain in HIV care.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ndolage District Hospital, Kamachumu, Kagera, Tanzania
Retention of patients in HIV care following diagnosis and enrollment is a chronic challenge in both resource rich and resource poor settings (Rosen, Fox et al. 2007; WHO 2009; Fox and Rosen 2010), and is critical to the long-term success of HIV care and treatment scale-up. Most research on retention in care has focused on persons who are eligible for or have initiated antiretroviral therapy (ART), generally examined only demographic and clinical determinants. However, a large proportion of patients enrolled in HIV care (e.g., 45%, according to our data from 722 sub-Saharan African clinics) have not been determined to be ART-eligible and have not yet initiated ART; among these individuals, even less is known about the magnitude and determinants of non-retention in care. Retention in HIV care prior to ART initiation is a pre-requisite to: 1) optimal prophylaxis, diagnosis, and treatment of opportunistic illnesses (OIs); 2) effective secondary prevention of HIV transmission, such as by patient counseling and education, earlier diagnosis of infected family members and sexual partners, and prevention of mother to child transmission (PMTCT); and 3) more timely ART initiation. Retention in care among patients at earlier disease stages is also increasingly important given the WHO-recommended expansion of ART eligibility guidelines in resource-limited settings (WHO 2009).
Objective: The goal of this study is to better understand barriers and enablers to retention and engagement in HIV care among adult patients who are enrolled in HIV care and are not yet eligible for ART. The specific objectives are:
Methods: This study will be conducted using qualitative and quantitative methods at four HIV care and treatment clinics (CTCs) in Kagera Region, Tanzania.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
QUALITATIVE COHORT
In-depth key informant interviews and focus groups will be conducted with patients that meet the following criteria:
ART-eligibility indeterminate patients (n= approximately 10 in-depth and up to 20 focus group participants, where half are from a rural site, Mugana District Hospital and half are from an urban site, Nyakahanga District Hospital)
i) Inclusion criteria:
ii) Exclusion criteria:
ART-ineligible patients (n= approximately 10 in-depth and up to 20 focus group participants, where half are from a rural site, Mugana District Hospital and half are from an urban site, Nyakahanga District Hospital)
i) Inclusion criteria:
ii) Exclusion criteria:
Health care workers will be purposefully selected for participation according to the following criteria:
i) Inclusion criteria:
ii) Exclusion criteria:
PROSPECTIVE COHORT
Patients that meet the following criteria will be included in the prospective study cohort:
i) Inclusion criteria:
ii) Exclusion criteria:
Time frame: 24 months
Columbia University
Other
Retention and Engagement in Care of Patients Prior to ART Initiation in the Kagera Region of Tanzania
Acronym: PARC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03182738
AIDS (Acquired Immunodeficiency Syndrome), Acquired Immunodeficiency Syndrome
New York, United States
View Trial DetailsNCT07620197
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial DetailsNCT05933824
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Zhengzhou, Henan, China
View Trial DetailsNCT07468487
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Tuzla, Istanbul, Turkey (Türkiye)
View Trial Details